
1. circulation. 2017 oct 17;136(16):1509-1524. doi:
10.1161/circulationaha.117.029003. epub 2017 jul 28.

in vivo functional selection identifies cardiotrophin-1 cardiac engraftment 
factor mesenchymal stromal cells.

bortolotti f(1), ruozi g(1), falcione a(1), doimo s(1), dal ferro m(1), lesizza
p(1), zentilin l(1), banks l(1), zacchigna s(1), giacca m(2).

author information: 
(1)from molecular medicine (f.b., g.r., a.f., l.z., m.g.), tumour biology (l.b.),
and cardiovascular biology (s.z.) laboratories, international centre genetic 
engineering biotechnology, trieste, italy; department medical, surgical
and health sciences, university trieste, italy (s.d., m.d.f., p.l., s.z.,
m.g.); center translational cardiology, azienda sanitaria integrata di
trieste, italy (s.d., m.d.f., p.l., s.z., m.g.).
(2)from molecular medicine (f.b., g.r., a.f., l.z., m.g.), tumour biology (l.b.),
and cardiovascular biology (s.z.) laboratories, international centre genetic 
engineering biotechnology, trieste, italy; department medical, surgical
and health sciences, university trieste, italy (s.d., m.d.f., p.l., s.z.,
m.g.); center translational cardiology, azienda sanitaria integrata di
trieste, italy (s.d., m.d.f., p.l., s.z., m.g.). giacca@icgeb.org.

comment in
    circulation. 2017 oct 17;136(16):1525-1527.

background: transplantation cells infarcted heart significant
potential improve myocardial recovery; however, low efficacy cell
engraftment still limits therapeutic benefit. here, describe method 
unbiased, vivo selection cytokines improve mesenchymal stromal cell
engraftment heart normal conditions myocardial
infarction.
methods: arrayed library 80 secreted factors, including the
currently known interleukins chemokines, individually cloned into
adeno-associated viral vectors. pools library used the
batch transduction bone marrow-derived mesenchymal stromal cells ex vivo,
followed intramyocardial cell administration normal infarcted mice.
three weeks injection, vector genomes recovered few
persisting cells identified sequencing dna barcodes uniquely labeling each
of tested cytokines.
results: effective molecule identified competitive engraftment
screening cardiotrophin-1, member interleukin-6 family. intracardiac
injection mesenchymal stromal cells transiently preconditioned with
cardiotrophin-1 preserved cardiac function reduced infarct size, parallel 
the persistence transplanted cells healing hearts least 2
months injection. engraftment cardiotrophin-1-treated mesenchymal
stromal cells consequent signal transducer activator transcription 
3-mediated activation focal adhesion kinase associated focal
adhesion complex consequent acquisition adhesive properties the
cells.
conclusions: results support feasibility selecting molecules vivo
for functional properties adeno-associated viral vector libraries 
identify cardiotrophin-1 powerful cytokine promoting cell engraftment and
thus improving cell therapy infarcted myocardium.

Â© 2017 american heart association, inc.

doi: 10.1161/circulationaha.117.029003 
pmid: 28754835  [indexed medline]

